BNR — BURNING ROCK BIOTECH LTD
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About BURNING ROCK BIOTECH LTD (BNR)
BURNING ROCK BIOTECH LTD (BNR) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $284,648. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BNR
How many top investors track BNR
Only 1 tracked investor report this position.
BNR Ownership Composition
How BURNING ROCK BIOTECH LTD is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting BNR
- Ken GriffinMar 31, 2026Citadel AdvisorsShares17.7KValue$284.6K% Portfolio0.00%
Recent activity
- New$284.6KMay 15, 2026
Frequently asked questions
- How many institutional investors hold BNR?
- 1 tracked institutional investor disclosed a position in BNR (BURNING ROCK BIOTECH LTD) in their most recent 13F filing.
- Who is the largest institutional holder of BNR?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in BNR, valued at $284,648.
- Did institutional ownership of BNR increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited BNR.
- Where does this BNR ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.